List view / Grid view
The US FDA has approved Amgen’s Wezlana (ustekinumab-auub) as the…
The US FDA has approved Amgen’s Wezlana (ustekinumab-auub) as the first biosimilar to reference blockbuster drug Stelara (ustekinumab).
Rituxan (rituximab) is the first approved treatment for children with…
Rituxan (rituximab) is the first approved treatment for children with rare vasculitis diseases, in which a patient’s small blood vessels become inflamed.
The FDA has approved the first treatment for interstitial lung…
The FDA has approved the first treatment for interstitial lung disease associated with systemic sclerosis or scleroderma.
